Kimera Labs specializes in the production of high-purity exosomes derived from perinatal mesenchymal stem cells (MSCs), focusing on their application in both cosmetic and research fields. The company employs advanced isolation technologies to ensure that their exosome products meet optimal pharmaceutical-grade standards. By utilizing chemically defined media that is free from animal or human serum, Kimera Labs adheres to FDA regulations while producing exosomes that are believed to stimulate healing and tissue regeneration. Their commitment to quality is reflected in their rigorous characterization processes, which include techniques such as ELISA protein analysis, high-pressure liquid chromatography (HPLC), and RNA sequencing, ensuring the consistency and purity of their exosome products.

In addition to their production capabilities, Kimera Labs is at the forefront of exosome research and innovation, actively pursuing advancements in exosome-based therapeutics and diagnostics. The company operates state-of-the-art facilities equipped with ISO 5 hoods and class 7 clean rooms, allowing for the development of engineered exosomes and optimized delivery systems. Their collaborative approach involves post-doctoral researchers working alongside physicians to create new diagnostic and treatment modalities. Kimera Labs is also dedicated to educating healthcare providers and scientists about exosome technology, aiming to accelerate the development of effective exosome-based solutions in regenerative medicine.

United States

Since 2012, we are a biotechnology company developing MSC exosome products for research and therapeutic purposes. We have focused on regenerative medicine and aesthetic applications by producing quality assured, GMP grade, purified nanovesicles in a 27,000 sq ft facility in Miami, Florida. 

Kimera Exosomes

Company Details